Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome
Cumali Efe, Ersan Ozaslan, Taylan Kav, Tugrul Purnak, Ali Shorbagi,Ozgur Ozkayar, Alexandra Heurgue Berlot, Cenk Sokmensuer, Paolo Muratori.
- Elsevier Science bv, 2012.
Background and aim: The aim of the present study was to assess the efficacy and tolerability of budesonide as an alternative first line treatment option for autoimmune hepatitis (AIH) and the overlap syndrome.
1568-9972
WOS:000302185300007
Immunology Near East University Article Yakın Doğu Üniversitesi Makale